CannaPharmaRX, Inc. (CPMD)
OTCMKTS · Delayed Price · Currency is USD
0.0021
0.00 (0.00%)
Jul 24, 2026, 3:11 PM EST

CannaPharmaRX Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.651.360.82---
Revenue Growth
46.45%66.09%----
Gross Profit
-2.43-2.39-2.93-0.07-0.03-
Operating Income
-3.35-3.35-3.63-1.58-5.21-2.62
Net Income
-10.82-11.13-9.913.69-8.53-8.83
Earnings Per Share
-0.02-0.02-0.020.01-0.04-0.12
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
000000.03
Total Debt
25.4520.6514.0612.9414.529.02
Net Cash (Debt)
-25.45-20.65-14.06-12.93-14.52-8.99
Net Cash Growth
------
Net Cash Per Share
-0.04-0.03-0.02-0.04-0.07-0.12

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.43-0.79-1.7-2.27-1.45-2.41
Capital Expenditures
-0.01-0.01--0.08-0.12-0.01
Free Cash Flow
-0.44-0.79-1.7-2.36-1.56-2.42
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-146.68%-175.34%----
Operating Margin
-202.65%-245.77%-442.72%---
Pretax Margin
-654.22%-817.19%-1207.82%---
Profit Margin
-654.22%-817.19%-1207.82%---
FCF Margin
-26.41%-58.34%-206.94%---

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---0.20--
PS Ratio
0.852.516.48---